Skip to main content

Table 2 Process times for patients who became symptomatic before first blood sampling or before the first screening result was available

From: Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *

Diagnosis

Age at decom-pensation

(days)

Age at blood samp-ling 1st screening card (days)

Age at 1st screening result (days)

Age at con-firmed diagnosis (days)

Age at start of treatment (days)

MCADD

0.0

4.0

11.0

12.0

14.0

MCADD

3

1.7

6.8

6.0

3.0

CIT I classic

1.0

3.0

12.0

2.0

2.0

CIT I classic

1.0

3.0

10.0

5.0

Not available

CIT I classic

2.0

2.7

8.6

2.0

2.0

IVA classic

3.0

4.4

10.7

8.0

8.0

PA

3.0

3.0

16.0

3.0

3.0

Cobalamin C/D defect

3.0

5.0

15.0

5.0

5.0

Galactosaemia

4.0

3.5

7.0

8.0

7.0

Galactosaemia

8.0

4.2

11.1

9.0

9.0

MSUD

4.0

3.4

9.3

5.0

5.0

  1. Abbreviations see Table 1
  2. Bold text indicates that the first screening result arrived after confirmed diagnosis.